Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of Nov. 21 to Nov. 25, 2016.
1. CMS proposed 2017 physician fee schedule eliminates moderate sedation from endoscopic procedures: 6 things to know
Click here
2. Boston Scientific hedges bets on endoscopic division, analysts project $5B valuation: 6 things to know
Click here
3. Valeant could sell Salix Pharmaceuticals to Takeda for $10B in cash grab: 7 things to know
Click here
4. The 16 items on MACRA's GI measure set for 2017
Click here
5. Inflammatory bowel disease 3 times more common than previous estimates: 5 takeaways
Click here
More articles on gastroenterology/endoscopy:
Boston Scientific hedges bets on endoscopic division; Allergan selects IBS spokesperson & more: 4 GI company key notes
Metastatic tumor-destroying vaccine for colon cancer patients to begin phase II trial: 6 key notes
Boston Scientific closes EndoChoice purchase: 4 things to know